News
20h
SurvivorNet on MSNImmunotherapy For Small Cell Lung Cancer: Groundbreaking New Developments Offer Hope To PatientsFor the first time in years, small cell lung cancer (SCLC) patients have reason for renewed hope as more treatment options ...
1don MSN
A federal judge is weighing a request from the Trump administration to unseal records of the FBI's surveillance of Martin ...
3d
Zacks Investment Research on MSNAmgen's Imdelltra Cuts Lung Cancer Death Risk by 40% in Phase IIIAmgen AMGN announced encouraging new data from its interim analysis of the global late-stage study evaluating Imdelltra ...
While the approval is a historic event for the BiTE drug class in solid tumours, the market share opportunity is restricted ...
The field of Cancer Immunity & Immunotherapy is entering an exciting new phase. While Volume I (see here) of this Research Topic highlighted broad ...
Amgen has detailed a positive phase 3 readout for its T-cell engager Imdelltra in previously treated small cell lung cancer ...
A judge is weighing whether to release files related to the assasination of Dr. Martin Luther King Jr. earlier than planned.
2d
MedPage Today on MSN'Immediately Practice-Changing' Trial in Small Cell Lung CancerCHICAGO -- The bispecific T-cell engager tarlatamab (Imdelltra) significantly prolonged survival in the second-line treatment ...
Trump executive order prompts request to release FBI wiretap records two years early, over objections by the civil rights ...
After one inmate died and four others were injured in a recent Bibb County Jail altercation, community leaders are urging ...
A federal judge said it could take years to negotiate the release of any files related to the FBI's surveillance of the Rev. Martin Luther King Jr.
A new study is the first phase 3 to show meaningful improvement in both progression-free and overall survival with first-line ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results